{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:28:19Z","timestamp":1774538899275,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Adipose tissue is a dynamic endocrine organ, a highly active metabolic tissue, and an important source of cytokines. Inflammatory factors play an important role in visceral obesity associated with insulin resistance (IR), metabolic syndrome (MS), hypertension, non-alcoholic fatty liver disease (NAFLD), diabetes mellitus type 2 (DM2), endothelial dysfunction (ED) and atherosclerosis.<\/jats:p><jats:p><jats:bold>Objectives:<\/jats:bold> To examine corelation of siMS score, as a quantification method for metabolic syndrome (MS), with insulin resistance, glucoregulation parameters, as with other co-founding factors of MS, inflammation and thrombosis factors, microalbuminuria, uric acid, fatty liver index (FLI) and homocysteine.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The study included 451 obese individuals with pre\u2013metabolic syndrome (pre-MS) and MS (age 16\u201375, body mass index (BMI) &amp;gt; 25kg\/m<jats:sup>2<\/jats:sup>) classified into two groups: I-age 10\u201330 (167 patients); II-age 31\u201375 (284 patients). International Diabetes Federation (IDF) classification was applied for diagnosing metabolic syndrome. Patients with less than three criteria indicated below were considered pre-metabolic syndrome. siMS risk score was used.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> siMS score increased with age: I-3.03 \u00b1 0.87, II-3.27 \u00b1 0.90. siMS score correlated with associated factors of MS: hyperinsulinemia and IR, ALT, gama-GT, FLI, uric acid in both groups and CRP (<jats:italic>p<\/jats:italic> &amp;lt; 0.01) in group I. Correlations in II group: siMS score with PAI-1 (<jats:italic>p<\/jats:italic> = 0.01), microalbuminuria (<jats:italic>p<\/jats:italic> = 0.006), homocysteine \u200b\u200b(<jats:italic>p<\/jats:italic> = 0.076).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Correlation of siMS score with HOMA-IR confirmed that hyperinsulinism and insulin resistance are in the basis of MS. Correlation of siMS score with parameters of NAFLD, CRP, PAI-1, uric acid, microalbuminuria and homocysteine indicates that they are significant co-founding factors of MS. Correlation of siMS score with PAI-1, microalbuminuria, homocysteine, indicates higher risk for progression of endothelial dysfunction and atherosclerosis with age.<\/jats:p>","DOI":"10.3389\/fgene.2022.1041383","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:29:31Z","timestamp":1672824571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["siMS score- method for quantification of metabolic syndrome, confirms co-founding factors of metabolic syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"V.","family":"Dimitrijevic-Sreckovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Dobrosavljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Colak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ivanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gostiljac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gacic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Soldatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"International diabetes federation task force on epidemiology and prevention, hational heart, lung, and blood institute, American heart association, world heart federation, international atherosclerosis society, & international association for the study of ObesityHarmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome-a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet (London, Engl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J. Lipid Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/s0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \"hits","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1475-2891-12-37","article-title":"Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"de Carvalho","year":"2013","journal-title":"Nutr. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes care"},{"key":"B7","first-page":"789","article-title":"Metabolic syndrome, prediabetes, prevention of diabetes and vascular complications","volume-title":"Yugoslav study of atherosclerosis precursors in school children, 20 years of follow-up","author":"Dimitrijevic-Sreckovic","year":""},{"key":"B8","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1515\/CCLM.2007.259","article-title":"Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome","volume":"45","author":"Dimitrijevic-Sreckovic","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"B9","first-page":"1127","article-title":"Mediterranean cardioprotective nutrition","volume-title":"Yugoslav study of atherosclerosis precursors in school children, 20 years of follow-up","author":"Dimitrijevic-Sreckovic","year":""},{"key":"B10","first-page":"731","article-title":"Metabolic sindrome in children and adolescents","volume-title":"Yugoslav study of atherosclerosis precursors in school children, 20 years of follow-up","author":"Dimitrijevic-Sreckovic","year":"2011"},{"key":"B11","first-page":"37","article-title":"Metabolic sindrome, prediabetes and non alcoholic fatty liver diseases- treatment by Mediterranean diet","volume-title":"FASTING-A WAY TO LIFE- Christian fasting as a method for preventing and treating diabetes, atherosclerosis and cancer. (Vrnjci-Belgrade, Interklima-Grafika","author":"Dimitrijevic-Sreckovic","year":"2013"},{"key":"B12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1056\/NEJM198708063170605","article-title":"Insulin resistance in essential hypertension","volume":"317","author":"Ferrannini","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijge.2013.03.008","article-title":"Nonalcoholic fatty liver disease: Prevalence, influence on age and sex, and relationship with metabolic syndrome and insulin resistance","volume":"7","author":"Hui-Yun","year":"2013","journal-title":"Int. J. Gerontol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4236\/ojemd.2020.107010","article-title":"Mathematical translation of metabolic syndrome: Assessment of siMS score for metabolic syndrome and biochemical risks","volume":"10","author":"Khan","year":"2020","journal-title":"Open J. Endocr. Metab. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1515\/jpem-2018-0384","article-title":"Comparing the validity of continuous metabolic syndrome risk scores for predicting pediatric metabolic syndrome: The CASPIAN-V study","volume":"32","author":"Khoshhali","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"B17","article-title":"Chapter 25","volume-title":"Hepatology, A clinical textbook","author":"Mauss","year":"2009"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2337\/diacare.24.8.1403","article-title":"Fasting plasma homocysteine levels in the insulin resistance syndrome: The framingham offspring study","volume":"24","author":"Meigs","year":"2001","journal-title":"Diabetes care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"The antihypertensive and lipid-lowering treatment to prevent heart attack TrialMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"Officers","year":"2002","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/0002-9149(94)90676-9","article-title":"Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women","volume":"73","author":"Pouliot","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4149\/BLL_2018_121","article-title":"Continuous metabolic syndrome score (siMS) enables quantification of severity of cardiometabolic affliction in individuals not presenting with metabolic syndrome","volume":"119","author":"Sebekova","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jjcc.2014.11.010","article-title":"Biochemical view on \"Homocysteine and metabolic syndrome: From clustering to additional utility in prediction of coronary heart disease","volume":"65","author":"Sertoglu","year":"2015","journal-title":"J. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0146143","DOI":"10.1371\/journal.pone.0146143","article-title":"siMS score: Simple method for quantifying metabolic syndrome","volume":"11","author":"Soldatovic","year":"2016","journal-title":"PloS one"},{"key":"B24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11906-013-0344-5","article-title":"Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: Is it time for reappraisal?","volume":"15","author":"Soltani","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2298\/VSP180626132S","article-title":"The correlation between metabolic syndrome quantification scores and numerous laboratory parameters related to this syndrome","volume":"77","author":"Sreckovic","year":"2020","journal-title":"Vojnosanitetskipregled"},{"key":"B26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.dsx.2016.08.026","article-title":"Homocysteine is a marker for metabolic syndrome and atherosclerosis","volume":"11","author":"Sreckovic","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/dmpt-2017-0013","article-title":"Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score","volume":"33","author":"Sreckovic","year":"2018","journal-title":"Drug Metab. Pers. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/diagnostics10060395","article-title":"Could SCGF-beta levels Be associated with inflammation markers and insulin resistance in male patients sufering from obesity-related NAFLD?","volume":"10","author":"Tarantino","year":"2020","journal-title":"Diagnostics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3748\/wjg.14.193","article-title":"Nonalcoholic fatty liver disease and mitochondrial dysfunction","volume":"14","author":"Wei","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI19246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1041383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:29:35Z","timestamp":1672824575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1041383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":30,"alternative-id":["10.3389\/fgene.2022.1041383"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.1041383","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1041383"}}